Replies to post #38747 on Ayala Pharmaceuticals Inc (fka ADXS)

[CATTDOGG12347]

It should become pretty obvious that something special is happening very early, just as we saw in the anal cancer trial.

[DewDiligence]

AIM2CERV is a quadruple-blinded trial. No one will know how well AXAL is performing until the formal data analysis is done.